Fauci warns politicization and weakened peer review threaten U.S. science

Fauci warns – Anthony Fauci, who led the National Institute of Allergy and Infectious Diseases from 1984 to 2022 and advised the public through HIV/AIDS, Ebola, and COVID outbreaks, says American science is “generally quite good” but faces a serious threat from politicizati

Anthony Fauci has spent decades watching biomedical research move from one breakthrough to the next—often under pressure. and always under scrutiny. He is now looking at the United States from a different angle: not at the virus curves or lab protocols. but at the machinery that decides what science gets funded and how it gets judged.

Fauci. the American physician-scientist who led the National Institute of Allergy and Infectious Diseases from 1984 to 2022. has also served as a key public health adviser during multiple disease outbreaks. including HIV/AIDS. Ebola. and COVID. In an interview edited for length and clarity. he described American science as “generally quite good. ” then pointed to what he sees as a hard turn in the system—one driven by politics and resource fights rather than new data.

“The recent politicization of science by current leadership at the U.S. Department of Health and Human Services and the National Institutes of Health. ” Fauci said. is a serious threat to the country’s standing as the leading place for biomedical research. He tied that concern to attempts—unsuccessful so far—to significantly reduce the allocation of resources to the NIH.

In his view, the danger goes beyond budgets. Fauci said what needs to change is “even stronger pushback” against efforts to downgrade government-sponsored biomedical research, including what appears to be a weakening of peer review in favor of decision-making by political appointees.

That contrast—scientific capability on one side, political pressure on the other—runs through his comments. Fauci’s optimism is anchored not in policy promises, but in the momentum of discovery. He said he is “buoyed by the brilliance and energy of our younger generation” in science, especially biomedical research. He added that opportunities for major transforming advances are greater than ever. driven by technologies such as mRNA platforms. artificial-intelligence-accelerated discovery. systems immunology. engineered antibodies and immune modulators. and CRISPR and other next-generation diagnostics.

In his own field at the interface of infectious diseases and the immune system, he said change has been rapid. “With the help of AI,” Fauci said, “we are no longer just fighting infections—we are learning to anticipate them, model them and even design immunity against them.”

He also offered counsel to those entering the field. telling early-career scientists to “follow your passion and not be discouraged by the current stress on the system.” Fauci said the opportunities and sources of gratification and accomplishment that await them “will be very fulfilling and rewarding. ” adding that along the way. they should “not forget to have some fun!”.

If there is a single message linking his warning to his optimism. it is that the future of biomedical research depends on both scientific tools and the institutions that govern their use. The sequence is stark in the facts he laid out: politicization and resource threats loom at the NIH. peer review could be weakened through political decision-making. and yet the pace of discovery continues—powerfully enough that. in Fauci’s words. researchers can now anticipate infections and even design immunity.

As Fauci puts it, the system’s stress is real. But the scientific engine, powered by newer methods and younger investigators, is still running—leaving the question hanging where it belongs, not in speeches, but in who controls the funding and the standards that decide which ideas move forward.

Anthony Fauci NIH peer review biomedical research politicization of science FDA HHS infectious diseases immune system mRNA platforms AI-accelerated discovery CRISPR engineered antibodies